Biohaven
BHVN
264 hedge funds and large institutions have $1.26B invested in Biohaven in 2025 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 87 increasing their positions, 74 reducing their positions, and 32 closing their positions.
63% more call options, than puts
Call options by funds: $84.9M | Put options by funds: $52.1M
56% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 32
18% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 74
6% more funds holding
Funds holding: 249 → 264 (+15)
3% more capital invested
Capital invested by funds: $1.23B → $1.26B (+$36.7M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5.48% less ownership
Funds ownership: 85.19% → 79.71% (-5.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$25M |
| 2 |
IAM
Infinitum Asset Management
Fort Lauderdale,
Florida
|
+$16.7M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$16.5M |
| 4 |
SC
Stempoint Capital
New York
|
+$12.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$92.8M |
| 2 |
AC
Armistice Capital
New York
|
-$31.1M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
-$18.7M |
| 4 |
JP Morgan Chase
New York
|
-$18M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.9M |
BHVN Hedge Fund Activity: Q3 2025 in Review
264 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q3 2025, worth a combined $1.26B — up 3% from $1.23B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new BHVN positions and 32 closed out — a net gain of 18 holders — while 87 added to existing stakes and 74 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $25M. The largest seller was Vanguard Group, cutting an estimated $92.8M.
- 264 institutional investors held Biohaven (BHVN) as of Q3 2025, up from 249 in Q2 2025.
- Funds reported $1.26B of Biohaven stock for Q3 2025, up 3% quarter-over-quarter.
- 50 funds opened new Biohaven positions in Q3 2025 and 32 closed out, a net change of +18 holders.
- The largest Biohaven buyer in Q3 2025 was Janus Henderson Group, an estimated $25M added.
- The largest Biohaven seller in Q3 2025 was Vanguard Group, an estimated $92.8M sold.
Based on aggregated 13F filings for Q3 2025.